Charnwood Lighthouse Lab Goes Live Processing Thousands of COVID-19 Tests per Day with PerkinElmer Solutions

UK’s newest Lighthouse Lab boosts the country’s COVID-19 testing capacity, while generating hundreds of new local jobs   WALTHAM, Mass. – November 30, 2020 – PerkinElmer, Inc., announced today the Lighthouse Lab in Charnwood, Loughborough, England is now processing COVID-19 testing samples as part of the Company’s collaboration with the Department of Health and Social... Read more

Key Regulatory Body in India Grants Commercial License for Fluidigm Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay

Nov 24, 2020 Fluidigm Assay is Among First Saliva-Based COVID-19 Tests Licensed for Use by Designated Labs in India SOUTH SAN FRANCISCO, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the Central Drugs Standard Control Organisation (CDSCO) in India has licensed importation and... Read more

Zymo Research Receives CE IVD Mark for Its Quick-DNA/RNA Viral MagBead Kit

RELIABLE AND SENSITIVE VIRAL PURIFICATION USED FOR SARS-COV-2 VIRAL DETECTION AND ANALYSIS Zymo Research’s Quick-DNA/RNA Viral MagBead Kit has been cleared for in vitro diagnostic applications for use by EU member states. IRVINE, Calif., (Nov. 23, 2020) — Zymo Research announced today that its Quick-DNA/RNA Viral MagBead Kit was cleared for distribution to the European Union (EU) common market.... Read more

QIAGEN collaborates with BioNTech on companion diagnostics development for HPV-associated squamous cell carcinoma of the head and neck

Hilden, Germany and Germantown, Maryland, November 18, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic collaboration with BioNTech SE (Nasdaq: BNTX) to develop and commercialize a tissue-based companion diagnostic – to be used with investigational cancer treatment BNT113 – which identifies patients with squamous cell carcinoma of the head... Read more

Fluidigm COVID-19 Community Connect Program Builds a Network of Testing Partners to Increase Access of Saliva-Based SARS-CoV-2 Testing for Communities

SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced COVID-19 Community Connect, a program to link federal, state and local governmental entities, public health agencies, academic institutions, workforces, individuals and a network of high-complexity labs to deliver saliva-based... Read more

Zymo Research Obtains CE IVD Mark for Its Quick SARS-CoV-2 Multiplex Kit

LOW COST, HIGH-SENSITIVITY DIAGNOSTIC TEST FOR COVID-19 DETECTION Zymo Research was recently granted the CE IVD certification for its Quick SARS-CoV-2 Multiplex Kit. IRVINE, Calif., (Nov. 10, 2020) — Zymo Research announced today that it obtained a CE IVD mark for the Quick SARS-CoV-2 Multiplex Kit in compliance with the Directive 98/79/EC of the European Parliament and of... Read more

Bringing Ultra-High Field MR Imaging from Research to Clinical: SIGNA 7.0T FDA Cleared

Waukesha, WI – November 10, 2020 – GE Healthcare today announced U.S. FDA 510(k) clearance of SIGNA 7.0T magnetic resonance imaging (MRI) scanner, the world’s most powerful FDA-cleared MRI device available. With a magnet approximately five times more powerful than most clinical systems, SIGNA 7.0T https://www.ge.com/news/press-releases/bringing-ultra-high-field-mr-imaging-from-research-to-clinical-signa-70t-fda-cleared Read more

Fluidigm and Healthvana Partner to Offer COVID-19 Test Results Delivery through Innovative Digital Platform

Patients Receive Results, Education and Next Steps on Their Mobile Phones to Prevent Further Spread of the Disease SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has partnered with Healthvana Inc., the nation’s leading patient platform... Read more

Tampa General Hospital and GE Healthcare's CareComm Saves $40 Million, Cuts 20,000 Excess Days and Reduces Length of Stay

Tampa, FL – October 29, 2020 – Tampa General Hospital (TGH), in partnership with GE Healthcare, reports a $40M reduction of system-wide inefficiencies since launching their CareComm command center with GE’s Command Center Software last August.  Utilizing 20 artificial intelligence applications (aka Tiles), CareComm helps to optimize minute-to-minute patient care operations with real-time actionable information used in CareComm... Read more